SUMMARY Histocompatibility antigen (HLA A, B and DR) serotyping was performed on 65 patients with motor neuron disease in the northern region of England and compared to a large control population from the Newcastle upon Tyne area. Thirty two patients had amyotrophic lateral sclerosis, 17 had progressive bulbar palsy and 16 had progressive muscular atrophy. Ten patients had a more slowly progressive course. No significant HLA associations were observed in the motor neuron disease patients. Subdivision of the patients by the clinical course of their disease did not reveal any significant associations. Forty six motor neuron disease patients from the Newcastle upon Tyne area had a reduced frequency of HLA DR4 compared to the local control population. The relevance of histocompatibility antigens to the pathogenesis of motor neuron disease is discussed. patients with motor neuron disease is divided into those living in the north eastern part of the Region predominantly around the city of Newcastle upon Tyne and therefore more directly comparable with the control group and those from Cumbria who might theoretically be expected to have a different pattern of HLA antigen frequency. In the larger group of motor neuron disease patients from the Newcastle upon Tyne area the decrease of HLA DR4 (p < 005) and the increase of HLA DR3 (not significant) compared to the control group are more marked than in the smaller Cumbrian population which has HLA frequencies more similar to those of the control population from the Newcastle upon Tyne area.
Discussion
Most of the reported HLA series in motor neuron disease have been retrospective. Since patients dying early in the course of the disease are not then studied the HLA distribution may be biased by factors which influence prognosis. When we began to analyse the HLA distribution in our patients in mid-1982, 15 patients, who had been diagnosed after January of 1981 as having motor neuron disease, had already died and are necessarily excluded from the study. However, the finding of a similar trend of distribution of HLA phenotypes in the groups of patients being diagnosed prior to and after January 1981 suggest that there is probably no significant difference between the HLA phenotypes of the patients with acute or more chronic forms of the disease.
Previous studies of HLA antigens in motor neuron disease have been limited to A and B locil 2 4 5 7 except for two reports of HLA D frequencies.3 6 As the DR antigen is at present the closest marker of the HLA gene involved in regulating immune response (Ir gene), it is therefore particularly relevant to study the DR locus in a disease which might possibly have an immune pathogenesis. " This study is the largest series of patients in whom DR serotype has been determined and we have shown a small but not statistically significant reduction in the DR4 phenotype. However, if the absence of the DR4 antigen were important in the pathogenesis of motor neuron disease, it is difficult to account for the unexpected finding of a relatively higher frequency of DR4 antigen in the motor neuron disease patients from Cumbria, when this region has been recognised to have a particularly high incidence of motor neuron disease (Quizilbash and Bates, unpublished) . Although immunological mechanisms may have an important role in the pathogenesis of this relentless disease, the results of different HLA antigen studies from various centres throughout the world would argue against a strong association of motor neuron disease with any particular antigen. It is to be hoped that with the increased availability of DR locus typing, more studies will be undertaken to assess the importance of these antigens in motor neuron disease. 
